|
|
|
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Title of each class:
|
|
Trading Symbol(s)
|
Name of each exchange on which registered:
|
|
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
☒
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
Page
|
||
PART I
|
||
ITEM 1.
|
5 |
|
ITEM 1A.
|
23 |
|
ITEM 1B.
|
51 |
|
ITEM 1C.
|
51 |
|
ITEM 2.
|
52 |
|
ITEM 3.
|
52 |
|
ITEM 4.
|
53 |
|
PART II
|
||
ITEM 5.
|
53 |
|
ITEM 6.
|
54 |
|
ITEM 7.
|
54 |
|
ITEM 7A.
|
76 |
|
ITEM 8.
|
76 |
|
ITEM 9.
|
76 |
|
ITEM 9A.
|
76 |
|
ITEM 9B.
|
77 |
|
ITEM 9C.
|
77 |
|
PART III
|
||
ITEM 10.
|
78 |
|
ITEM 11.
|
81 |
|
ITEM 12.
|
86 |
|
ITEM 13.
|
88 |
|
ITEM 14.
|
88 |
|
PART IV
|
||
ITEM 15.
|
90 |
|
ITEM 16.
|
92 |
|
92 |
● |
Able2rent GmbH (“Able2rent” when individually referenced), a German company and a 50% subsidiary of Cenntro Automotive Europe GmbH;
|
● |
Avantier Motors Company (“Avantier” when individually referenced), a Delaware company and a wholly owned subsidiary of Cenntro Electric Group, Inc.;
|
● |
Avantier Motors (Hong Kong) Limited (“Avantier HK” when individually referenced), a Hong Kong company and a wholly-owned subsidiary of Avantier;
|
● |
Cennatic Power, Inc. (“Cennatic” when individually referenced), a Delaware company and a wholly owned subsidiary of Cenntro Electric Group, Inc.;
|
● |
Cennatic Energy S. de R.L. de C.V. (“Cennatic MX” when individually referenced), a Mexican company and 99% subsidiary of Cennatic and 1% subsidiary of Cenntro Automotive Corporation;
|
● |
Cenntro Automotive Corporation (“CAC” when individually referenced), a Delaware company and a wholly-owned subsidiary of Cenntro Electric Group Limited ACN 619 054 938;
|
● |
Cenntro Automotive Europe GmbH (formerly Tropos Motors Europe GmbH or “TME”) (“CAE” when individually referenced), a German company and wholly-owned subsidiary of Cenntro Electric Group, Inc;
|
● |
Cenntro Automotive S.A.S. (“CA COL” when individually referenced), a Colombian company and wholly-owned subsidiary of CAC;
|
● |
Cenntro Elecautomotiv, S.L. (“CE SPAIN” when individually referenced), a Spanish company and wholly-owned subsidiary of CE EU;
|
● |
Cenntro Electric B.V. (“CEBV” when individually referenced), a Dutch company and wholly-owned subsidiary of Cenntro Electric Group, Inc.;
|
● |
Cenntro Electric CIC, SRL (“CEG DOM” when individually referenced), a Dominican company and 99%-owned subsidiary of Cenntro Automotive Corporation;
|
● |
Cenntro Electric Colombia S.A.S. (“CE COL” when individually referenced), a Colombian company and wholly-owned subsidiary of CAC;
|
● |
Cenntro Electric Group Limited ACN 619 054 938, (“CEGL” when individually referenced), an Australian company and wholly-owned subsidiary of Cenntro, Inc.;
|
● |
Cenntro Electric Group (Europe) GmbH, (formerly Blitz F22-1 GmbH) (“CEGE” when individually referenced), a German company and wholly-owned subsidiary of CEBV.;
|
● |
Cenntro Electric Group, Inc. (“CEGI” when individually referenced), a Delaware company and a wholly-owned subsidiary of Cenntro Electric Group Limited ACN 619 054 938;
|
● |
Cenntro EV Center Italy S.R.L. (“CEV Italy” when individually referenced), an Italian company and a wholly-owned subsidiary of CE EU;
|
● |
Cenntro Automotive Group Limited (“CAG HK” when individually referenced), a Hong Kong company and a wholly owned subsidiary of Cenntro Electric Group Limited ACN 619 054 938;
|
● |
Cenntro Technology Corporation (“CTC” when individually referenced), a California corporation and a wholly owned subsidiary of CEGI;
|
● |
Hangzhou Ronda Tech Co., Ltd. (“Ronda” when individually referenced), a PRC company and a wholly owned subsidiary of Cenntro Automotive Group Limited;
|
● |
Hangzhou Cenntro Autotech Co., Ltd. (“Autotech” when individually referenced), a PRC company and a wholly owned subsidiary of Cenntro Automotive Group Limited;
|
● |
Hangzhou Hengzhong Tech Co., Ltd. (“Hengzhong Tech” when individually referenced), a PRC company and a wholly owned subsidiary of Hangzhou Cenntro Autotech Co., Ltd.;
|
● |
Pikka Electric Corporation (“PEC” when individually referenced), a Delaware corporation and a wholly owned subsidiary of CEGI;
|
● |
Shengzhou Cenntro Machinery Co., Ltd. (“Shengzhou Machinery” when individually referenced), a PRC company and a wholly owned subsidiary of Hangzhou Cenntro Autotech Co., Ltd.;
|
● |
Simachinery Equipment Limited (“Simachinery Equipment” when individually referenced), a Hong Kong company and a wholly owned subsidiary of Cenntro Automotive Group Limited;
|
● |
Teemak Power Corporation (“Teemak” when individually referenced), Delaware company and a wholly owned subsidiary of Cenntro Electric Group, Inc.;
|
● |
Teemak Power (Hong Kong) Limited (“Teemak HK” when individually referenced), a Hong Kong company and a wholly-owned subsidiary of Teemak;
|
● |
Zhejiang Cenntro Machinery Co., Ltd. (“Zhejiang Machinery” when individually referenced), a PRC company and a wholly owned subsidiary of Cenntro Automotive Group Limited;
|
● |
Zhejiang Sinomachinery Co., Ltd. (“Zhejiang Sinomachinery” when individually referenced), a PRC company and a wholly owned subsidiary of Simachinery Equipment Limited;
|
● |
Jiangsu Tooniu Tech Co., Ltd. (“Tooniu” when individually referenced), a PRC company and a wholly owned subsidiary of Cenntro Automotive Group Limited;
|
● |
Zhejiang Xbean Tech Co. Ltd. (“Zhejiang Xbean” when individually referenced), a PRC company and a wholly owned subsidiary of Zhejiang Sinomachinery Co., Ltd.;
|
Item 1. |
Business
|
• |
China: End production and sales of ICE vehicles by 2040;
|
• |
France: Ban the sale of ICE cars by 2040;
|
• |
Germany: No registration of ICE vehicles by 2030 (passed by legislature); cities can ban diesel cars;
|
• |
India: Official target of no new ICE vehicles sold after 2030; Incentive program in place for EV sales;
|
• |
Japan: Incentive program in place for EV sales; and
|
• |
United Kingdom: Ban the sale of new ICE cars starting in 2030.
|
For the Year Ended December 31,
|
||||||||||||||||
2023
|
2022
|
|||||||||||||||
$ |
|
%
|
$ |
|
%
|
|||||||||||
United States
|
$ | 34,990 |
4.63
|
%
|
$
|
697,452
|
7.80
|
%
|
||||||||
Europe
|
$
|
1,021,205
|
73.45
|
%
|
$
|
7,052,452
|
78.87
|
%
|
||||||||
Asia
|
$
|
16,218,398
|
21.76
|
%
|
$
|
1,191,931
|
13.33
|
%
|
||||||||
Others
|
$
|
4,805,312
|
0.16
|
%
|
-
|
-
|
Functional Area
|
Number of
Employees
|
|||
Senior management
|
7
|
|||
Research and Development
|
64
|
|||
Supply Chain Operations
|
36
|
|||
Marketing
|
37
|
|||
Manufacturing
|
77
|
|||
Quality Assurance
|
27
|
|||
Finance
|
25
|
|||
Corporate Affairs
|
42
|
|||
Total
|
315
|
Item 1A. |
Risk Factors.
|
• |
design and manufacture safe, reliable and quality ECVs on an ongoing basis;
|
• |
establish and ramp up assembly facilities in the United States and European Union;
|
• |
maintain and expand our network of local assembly facilities, manufacturing partners, channel partners and suppliers;
|
• |
execute on our growth plan to regionalize supply chains, manufacturing and assembly of our ECVs;
|
• |
maintain and improve our operational efficiency;
|
• |
maintain a reliable, high quality, high-performance and scalable manufacturing and assembly infrastructure;
|
• |
attract, retain and motivate talented employees including our production workforce in existing and planned facilities, including the challenges we face with COVID-19 and the impact on our workforce
stability;
|
• |
anticipate and adapt to changing market conditions, including technological developments and changes in the competitive landscape;
|
• |
protect our intellectual property; and
|
• |
navigate an evolving and complex regulatory environment.
|
• |
accurately manufacturing or procure components within appropriate design tolerances;
|
• |
establishing additional manufacturing and local assembly facilities in our various target markets;
|
• |
compliance with environmental, workplace safety and similar regulations;
|
• |
securing necessary high-quality components and materials from our supply chain on acceptable terms and in a timely manner;
|
• |
our ability to execute on our growth plan to regionalize our supply chain and manufacturing;
|
• |
quality controls;
|
• |
delays or disruptions in the supply chain, including as a result of pandemics such as COVID-19;
|
• |
delays or disruptions in ocean transit or transportation between our suppliers, our manufacturing facilities (or manufacturing partners’ facilities) and our local assembly facilities and our customers;
|
• |
our ability to establish, maintain and rely upon relationships with our suppliers, channel partners and manufacturing partners; and
|
• |
other delays, backlog in manufacturing and research and development of new models, and cost overruns.
|
• |
Slower spending may result in reduced demand for our ECVs, reduced orders from our channel partners, order cancellations, lower revenues, higher discounts, increased inventories and lower gross margins.
|
• |
Continued volatility in the markets and exchange rates for foreign currencies and contracts in foreign currencies could have a significant impact on our reported operating results and financial
condition. We conduct transactions in various currencies, which increases our exposure to fluctuations in foreign currency exchange rates relative to the U.S. Dollar.
|
• |
Volatility in the availability and prices for commodities and raw materials we use in our ECVs from our supply chain could have a material adverse effect on our costs, gross margins and profitability.
|
• |
Instability in global financial and capital markets may impair our ability to raise additional equity or debt financing on reasonable terms or at all in order to grow our business.
|
• |
perceptions about electric vehicle quality, safety, design, performance and cost, especially if adverse events or accidents occur that are linked to the quality or safety of electric vehicles, whether
or not such vehicles are produced by us or other manufacturers;
|
• |
perceptions about vehicle safety in general, in particular safety issues that may be attributed to the use of advanced technology, including electric vehicle systems;
|
• |
the limited range over which electric vehicles may be driven on a single battery charge and the speed at which batteries can be recharged;
|
• |
the decline of an electric vehicle’s range resulting from deterioration over time in the battery’s ability to hold a charge;
|
• |
concerns about electric grid capacity and reliability;
|
• |
the availability of new energy vehicles, including plug-in hybrid electric vehicles and vehicles powered by hydrogen fuel;
|
• |
improvements in the fuel economy of the internal combustion engine;
|
• |
the availability of service for electric vehicles;
|
• |
the environmental consciousness of end-users;
|
• |
access to charging stations, standardization of electric vehicle charging systems and perceptions about convenience and cost to charge an electric commercial vehicle;
|
• |
the availability of tax and other governmental incentives to purchase and operate electric vehicles or future regulation requiring increased use of nonpolluting vehicles;
|
• |
perceptions about and the actual cost of alternative fuel; and
|
• |
macroeconomic factors.
|
• |
the inability or unwillingness of current battery cell manufacturers to build or operate battery cell manufacturing plants to supply the numbers of lithium-ion cells required to support the growth of
the electric vehicle industry as demand for such cells increases;
|
• |
disruption in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and
|
• |
an increase in the cost or shortages of raw materials, such as lithium, nickel and cobalt, used in lithium-ion cells.
|
• |
conforming our products to various international regulatory and safety requirements in establishing, staffing and managing foreign operations;
|
• |
challenges in attracting channel partners;
|
• |
compliance with foreign government taxes, regulations and permit requirements;
|
• |
our ability to enforce our contractual rights and intellectual property rights;
|
• |
compliance with trade restrictions and customs regulations as well as tariffs and price or exchange controls;
|
• |
fluctuations in freight rates and transportation disruptions;
|
• |
fluctuations in the values of foreign currencies;
|
• |
compliance with certification and homologation requirements; and
|
• |
preferences of foreign nations for domestically manufactured products.
|
• |
our pending patent applications may not result in the issuance of patents;
|
• |
our patents may not be broad enough to protect our commercial endeavors;
|
• |
the patents we have been granted may be challenged, invalidated or circumvented because of the pre-existence of similar patented or unpatented technology or for other reasons;
|
• |
the costs associated with obtaining and enforcing patents in the countries in which we operate, confidentiality and invention agreements or other intellectual property rights may make enforcement
impracticable; or
|
• |
current and future competitors may independently develop similar technology, duplicate our vehicles or design new vehicles in a way that circumvents our intellectual property protection.
|
• |
cease selling vehicles or incorporating or using designs or offering goods or services that incorporate or use the challenged intellectual property;
|
• |
pay substantial damages;
|
• |
obtain a license from the holder of the infringed intellectual property right, which license may not be available on reasonable terms or at all; or
|
• |
redesign our vehicles or other goods or services.
|
• |
our future financial performance, including expectations regarding our revenue, expenses and other operating results;
|
• |
changes in customer acceptance rates or the pricing of our vehicles;
|
• |
delays in the production of our vehicles;
|
• |
our ability to establish new channel partners and successfully retain existing channel partners;
|
• |
our ability to anticipate market needs and develop and introduce new and enhanced vehicles to adapt to changes in our industry;
|
• |
the success of our competitors;
|
• |
our operating results failing to meet the expectations of securities analysts or investors in a particular period;
|
• |
changes in financial estimates and recommendations by securities analysts concerning us or the industry in which we operate in general;
|
• |
the stock price performance of other companies that investors deem comparable to us;
|
• |
announcements by us or our competitors of significant business developments, acquisitions, strategic partnerships, joint ventures, collaborations or capital commitments;
|
• |
future investments in our business, our anticipated capital expenditures and our estimates regarding our capital requirements;
|
• |
disputes or other developments related to our intellectual property or other proprietary rights, including litigation;
|
• |
changes in our capital structure, including future issuances of securities or the incurrence of debt;
|
• |
changes in senior management or key personnel;
|
• |
changes in laws and regulations affecting our business;
|
• |
commencement of, or involvement in, investigations, inquiries or litigation;
|
• |
the inherent risks related to the electric commercial vehicle industry;
|
• |
the trading volume of our Common Stock; and
|
• |
general economic and market conditions.
|
Item 1B. |
Unresolved Staff Comments.
|
Item 1C. |
Cybersecurity.
|
Item 2. |
Properties.
|
Item 3. |
Legal Proceedings.
|
Item 4. |
Mine Safety Disclosures.
|
Item 5. |
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
|
High
|
Low
|
|||||||
Fiscal Year Ended December 31, 2023(1)
|
||||||||
First Quarter
|
$
|
0.87
|
$
|
0.35
|
||||
Second Quarter
|
$
|
0.49
|
$
|
0.28
|
||||
Third Quarter
|
$
|
0.50
|
$
|
0.23
|
||||
Fourth Quarter
|
$
|
1.59
|
$
|
1.21
|
||||
Fiscal Year Ended December 31, 2022
|
||||||||
First Quarter
|
$
|
5.57
|
$
|
1.05
|
||||
Second Quarter
|
$
|
2.30
|
$
|
1.34
|
||||
Third Quarter
|
$
|
1.82
|
$
|
0.95
|
||||
Fourth Quarter
|
$
|
1.20
|
$
|
0.26
|
(1) |
Accounts for a 1:10 reverse stock spit effective as of December 8, 2023.
|
Item 6. |
[Reserved]
|
Item 7. |
Management’s Discussion and Analysis of Financial Condition and Results of Operation.
|
A. |
Key Components of Results of Operations
|
Year ended December 31
|
||||||||
2023
|
2022
|
|||||||
Gross margin of vehicle sales
|
11.7
|
%
|
-0.27
|
%
|
|
Year Ended December 31,
|
|||||||
|
2023
|
2022
|
||||||
|
(Expressed in U.S. Dollars)
|
|||||||
Combined Statements of Operations Data:
|
||||||||
Net revenues
|
22,079,905
|
8,941,835
|
||||||
Cost of goods sold
|
(19,821,645
|
)
|
(9,455,805
|
)
|
||||
Gross profit/(loss)
|
2,258,260
|
(513,970
|
)
|
|||||
Operating Expenses:
|
||||||||
Selling and marketing expenses
|
(7,868,773
|
)
|
(6,525,255
|
)
|
||||
General and administrative expenses
|
(35,768,786
|
)
|
(32,822,709
|
)
|
||||
Research and development expenses
|
(8,469,241
|
)
|
(6,362,770
|
)
|
||||
Provision for doubtful accounts
|
—
|
(5,986,308
|
)
|
|||||
Reverse of Deferred tax liabilities
|
—
|
898,632
|
||||||
Impairment of ROU
|
—
|
(371,695
|
)
|
|||||
Impairment of Intangible assets
|
—
|
(2,995,440
|
)
|
|||||
Impairment of PPE
|
(431,319
|
)
|
(550,402
|
)
|
||||
Total operating expenses
|
(52,538,119
|
)
|
(54,715,947
|
)
|
||||
|
||||||||
Loss from operations
|
(50,279,859
|
)
|
(55,229,917
|
)
|
||||
|
||||||||
Other Income (Expense):
|
||||||||
Interest expense, net
|
402,414
|
(844,231
|
)
|
|||||
(Loss) Income from equity method investments
|
(222,349
|
)
|
(12,651
|
)
|
||||
Other (expense) income, net
|
621,633
|
(924,867
|
)
|
|||||
Loss on redemption of convertible promissory notes
|
12,507
|
(7,435
|
)
|
|||||
Change in fair value of convertible promissory notes and derivative liability
|
75,341
|
(37,774,928
|
)
|
|||||
Change in fair value of equity securities
|
(2,600,721
|
)
|
(240,805
|
)
|
||||
Convertible bond issuance cost
|
—
|
(5,589,336
|
)
|
|||||
Foreign currency exchange loss, net
|
(848,781
|
)
|
(409,207
|
)
|
||||
Impairment of Goodwill
|
—
|
(11,111,886
|
)
|
|||||
Gain (loss)from cross-currency swaps
|
8,664
|
—
|
||||||
Impairment of Long-term investments
|
(1,155,411
|
)
|
||||||
loss from acquisition of Antric
|
(136,302
|
)
|
||||||
Loss on exercise of warrants
|
(228,903
|
)
|
—
|
|||||
Loss before income taxes
|
(54,351,767
|
)
|
(112,145,263
|
)
|
||||
Income tax expense
|
(8,988
|
)
|
—
|
|||||
Net loss
|
(54,360,755
|
)
|
(112,145,263
|
)
|
||||
Less: net loss attributable to non-controlling interests
|
(161,430
|
)
|
(2,057,022
|
)
|
||||
Net loss attributable to shareholders of the Company
|
(54,199,325
|
)
|
(110,088,241
|
)
|
Year Ended December 31,
|
||||||||||||||||
2023
|
2022
|
|||||||||||||||
Amount
|
%
|
Amount
|
%
|
|||||||||||||
(Expressed in U.S. Dollars)
|
||||||||||||||||
Net revenues:
|
||||||||||||||||
Vehicle Sales
|
$
|
20,344,889
|
92.1
|
%
|
$
|
8,235,053
|
92.1
|
%
|
||||||||
Spare-part sales
|
1,554,311
|
7.1
|
%
|
304,506
|
3.4
|
%
|
||||||||||
Other sales
|
180,705
|
0.8
|
%
|
402,276
|
4.5
|
%
|
||||||||||
Total net revenues
|
$
|
22,079,905
|
100.00
|
%
|
$
|
8,941,835
|
100.00
|
%
|
Year Ended December 31,
|
||||||||||||||||
2023
|
2022
|
|||||||||||||||
Amount
|
%
|
Amount
|
%
|
|||||||||||||
(Expressed in U.S. Dollars)
|
||||||||||||||||
Cost of goods sold:
|
||||||||||||||||
Vehicle Sales
|
$
|
(17,375,714
|
)
|
87.7
|
%
|
$
|
(6,852,852
|
)
|
72.5
|
%
|
||||||
Spare-part sales
|
(1,534,172
|
)
|
7.7
|
%
|
(190,241
|
)
|
2.0
|
%
|
||||||||
Other sales
|
(253,136
|
)
|
1.3
|
%
|
(257,312
|
)
|
2.7
|
%
|
||||||||
Inventory write-down
|
(658,622
|
)
|
3.3
|
%
|
(2,155,400
|
)
|
22.8
|
%
|
||||||||
Total cost of goods sold
|
$
|
(19,821,645
|
)
|
100.00
|
%
|
$
|
(9,455,805
|
)
|
100.00
|
%
|
• |
as a measurement of operating performance because it assists us in comparing the operating performance of our business on a consistent basis, as it removes the impact of items not directly resulting from our core
operations;
|
• |
for planning purposes, including the preparation of our internal annual operating budget and financial projections;
|
• |
to evaluate the performance and effectiveness of our operational strategies; and
|
• |
to evaluate our capacity to expand our business.
|
• |
such measures do not reflect our cash expenditures;
|
• |
such measures do not reflect changes in, or cash requirements for, our working capital needs;
|
• |
although depreciation and amortization are recurring, non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and such measures do not reflect any cash requirements
for such replacements; and
|
• |
the exclusion of stock-based compensation expense, which has been a significant recurring expense and will continue to constitute a significant recurring expense for the foreseeable future, as equity awards are
expected to continue to be an important component of our compensation strategy.
|
|
Year Ended December 31,
|
|||||||
|
2023
|
2022
|
||||||
|
(Unaudited)
|
|||||||
Net loss
|
$
|
(54,360,755
|
)
|
$
|
(112,145,263
|
)
|
||
Interest expense, net
|
(402,414
|
)
|
844,231
|
|||||
Income tax expense
|
24,919
|
—
|
||||||
Depreciation and amortization
|
1,570,313
|
953,872
|
||||||
Share-based compensation expense
|
5,230,273
|
4,031,629
|
||||||
Expenses related to TME Acquisition
|
—
|
348,987
|
||||||
Expenses related to one-off payment inherited from the original Naked Brand Group
|
—
|
8,299,178
|
||||||
Impairment of goodwill
|
—
|
11,111,886
|
||||||
Convertible bond issuance cost
|
—
|
5,589,336
|
||||||
Loss on redemption of convertible promissory notes
|
(12,507
|
)
|
7,435
|
|||||
Loss on exercise of warrants
|
228,903
|
—
|
||||||
Change in fair value of convertible promissory notes and derivative liability
|
(75,341
|
)
|
37,774,928
|
|||||
Loss from acquisition of Antric
|
136,302
|
—
|
||||||
Adjusted EBITDA
|
$
|
(47,575,571
|
)
|
$
|
(43,183,781
|
)
|
For the Year Ended
|
||||||||||||||||||||||||
31 December 2023
|
31 December 2022
|
|||||||||||||||||||||||
Balance Sheet:
|
U.S. GAAP
|
IFRS Difference
|
IFRS
|
U.S. GAAP
|
IFRS Difference
|
IFRS
|
||||||||||||||||||
Current assets
|
||||||||||||||||||||||||
Cash and cash equivalents
|
29,375,727
|
-
|
29,375,727
|
153,966,777
|
-
|
153,966,777
|
||||||||||||||||||
Restricted cash
|
196,170
|
-
|
196,170
|
130,024
|
-
|
130,024
|
||||||||||||||||||
Short-term investment
|
4,236,588
|
-
|
4,236,588
|
-
|
-
|
-
|
||||||||||||||||||
Accounts receivable, net
|
6,530,801
|
-
|
6,530,801
|
565,398
|
-
|
565,398
|
||||||||||||||||||
Inventories
|
43,909,564
|
-
|
43,909,564
|
31,843,371
|
-
|
31,843,371
|
||||||||||||||||||
Prepayment and other current assets
|
20,391,150
|
-
|
20,391,150
|
16,138,330
|
-
|
16,138,330
|
||||||||||||||||||
Amount due from related parties - current
|
287,439
|
-
|
287,439
|
366,936
|
-
|
366,936
|
||||||||||||||||||
Total current assets
|
104,927,439
|
-
|
104,927,439
|
203,010,836
|
-
|
203,010,836
|
||||||||||||||||||
Non-current assets
|
||||||||||||||||||||||||
Long-term investments
|
4,685,984
|
-
|
4,685,984
|
5,325,741
|
-
|
5,325,741
|
||||||||||||||||||
Investment in equity securities
|
26,158,474
|
-
|
26,158,474
|
29,759,195
|
-
|
29,759,195
|
||||||||||||||||||
Property, plants and equipment, net
|
20,401,521
|
-
|
20,401,521
|
14,962,591
|
-
|
14,962,591
|
||||||||||||||||||
Goodwill
|
223,494
|
-
|
223,494
|
-
|
-
|
-
|
||||||||||||||||||
Intangible assets, net
|
6,873,781
|
-
|
6,873,781
|
4,563,792
|
-
|
4,563,792
|
||||||||||||||||||
Right-of-use assets
|
20,039,625
|
-
|
20,039,625
|
8,187,149
|
-
|
8,187,149
|
||||||||||||||||||
Other non-current assets, net
|
2,227,672
|
-
|
2,227,672
|
2,039,012
|
-
|
2,039,012
|
||||||||||||||||||
Total non-current assets
|
80,610,551
|
-
|
80,610,551
|
64,837,480
|
-
|
64,837,480
|
||||||||||||||||||
Total assets
|
185,537,990
|
-
|
185,537,990
|
267,848,316
|
-
|
267,848,316
|
||||||||||||||||||
Current liabilities
|
||||||||||||||||||||||||
Accounts payable
|
6,797,852
|
-
|
6,797,852
|
3,383,021
|
-
|
3,383,021
|
||||||||||||||||||
Accrued expense and other current liabilities
|
4,263,887
|
-
|
4,263,887
|
5,048,641
|
-
|
5,048,641
|
||||||||||||||||||
Contractual liabilities
|
3,394,044
|
-
|
3,394,044
|
2,388,480
|
-
|
2,388,480
|
||||||||||||||||||
Operating lease liabilities, current
|
4,741,599
|
-
|
4,741,599
|
1,313,334
|
-
|
1,313,334
|
||||||||||||||||||
Convertible promissory notes
|
9,956,000
|
-
|
9,956,000
|
57,372,827
|
-
|
57,372,827
|
||||||||||||||||||
Contingent liabilities
|
26,669
|
-
|
26,669
|
-
|
-
|
-
|
||||||||||||||||||
Deferred government grant, current
|
108,717
|
-
|
108,717
|
26,533
|
-
|
26,533
|
||||||||||||||||||
Amount due to related parties
|
10,468
|
-
|
10,468
|
716,372
|
-
|
716,372
|
||||||||||||||||||
Total current liabilities
|
29,299,236
|
-
|
29,299,236
|
70,249,208
|
-
|
70,249,208
|
||||||||||||||||||
Non-current liabilities
|
||||||||||||||||||||||||
Contingent liabilities – non-current
|
230,063
|
-
|
230,063
|
-
|
-
|
-
|
||||||||||||||||||
Deferred tax liabilities
|
228,086
|
-
|
228,086
|
-
|
-
|
-
|
||||||||||||||||||
Deferred government grant, non current
|
1,929,733
|
-
|
1,929,733
|
497,484
|
-
|
497,484
|
||||||||||||||||||
Derivative liability - investor warrant
|
12,189,508
|
-
|
12,189,508
|
14,334,104
|
-
|
14,334,104
|
||||||||||||||||||
Derivative liability - placement agent warrant
|
3,456,578
|
-
|
3,456,578
|
3,456,404
|
-
|
3,456,404
|
||||||||||||||||||
Operating lease liabilities, non current
|
16,339,619
|
-
|
16,339,619
|
7,421,582
|
-
|
7,421,582
|
||||||||||||||||||
Total non-current liabilities
|
34,373,587
|
-
|
34,373,587
|
25,709,574
|
-
|
25,709,574
|
||||||||||||||||||
Total liabilities
|
63,672,823
|
-
|
63,672,823
|
95,958,782
|
-
|
95,958,782
|
||||||||||||||||||
Equity
|
||||||||||||||||||||||||
Ordinary shares (No par value; 30,828,778 and 30,084,200 shares issued and outstanding as of 31 December 2023 and 2022, respectively)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Additional paid-in capital
|
402,337,393
|
176,895,202
|
(1)
|
579,232,595
|
397,497,817
|
182,125,475
|
(1)
|
579,623,292
|
||||||||||||||||
Accumulated other comprehensive loss
|
(6,444,485
|
)
|
6,444,485
|
-
|
(5,306,972
|
)
|
5,306,972
|
-
|
||||||||||||||||
Reserves
|
-
|
26,090,244
|
(2)
|
26,090,244
|
-
|
21,997,484
|
(2)
|
21,997,484
|
||||||||||||||||
Accumulated deficit
|
(274,023,501
|
)
|
(209,429,931
|
)
|
(483,453,432
|
)
|
(219,824,176
|
)
|
(209,429,931
|
)
|
(429,254,107
|
)
|
||||||||||||
Total equity attributable to shareholders
|
121,869,407
|
121,869,407
|
172,366,669
|
172,366,669
|
||||||||||||||||||||
Non-controlling interests
|
(4,240
|
)
|
(4,240
|
)
|
(477,135
|
)
|
-
|
(477,135
|
)
|
|||||||||||||||
Total Equity
|
121,865,167
|
121,865,167
|
171,889,534
|
171,889,534
|
||||||||||||||||||||
Total Liabilities and Equity
|
185,537,990
|
185,537,990
|
267,848,316
|
267,848,316
|
(1) |
Includes $(32,534,729) (2022: $(27,304,456)) in share-based compensation payments and additional equity of $209,429,931 recognised in 2021 from
the difference between the deemed transaction price and net assets acquired related to the Combination under IFRS.
|
(2) |
Includes (i) a reclassification of Accumulated other comprehensive loss under U.S. GAAP of $(6,444,485) (2022: $(5,306,972)) and (ii) a
reclassification of Additional paid-in capital under U.S. GAAP of $32,534,729 (2022: $27,304,456) in share-based compensation payments to Reserves under IFRS.
|
For the Year Ended
|
||||||||||||||||||||||||
31 December 2023
|
31 December 2022
|
|||||||||||||||||||||||
Statement of Operations:
|
U.S. GAAP
|
IFRS
Difference
|
IFRS
|
U.S. GAAP
|
IFRS
Difference
|
IFRS
|
||||||||||||||||||
Net revenues
|
22,079,905
|
-
|
22,079,905
|
8,941,835
|
-
|
8,941,835
|
||||||||||||||||||
Cost of goods sold
|
(19,821,645
|
)
|
-
|
(19,821,645
|
)
|
(9,455,805
|
)
|
-
|
(9,455,805
|
)
|
||||||||||||||
Gross profit (loss)
|
2,258,260
|
-
|
2,258,260
|
(513,970
|
)
|
-
|
(513,970
|
)
|
||||||||||||||||
OPERATING EXPENSE
|
||||||||||||||||||||||||
Selling and marketing expenses
|
(7,868,773
|
)
|
-
|
(7,868,773
|
)
|
(6,525,255
|
)
|
-
|
(6,525,255
|
)
|
||||||||||||||
General and administrative expenses
|
(35,768,786
|
)
|
-
|
(35,768,786
|
)
|
(32,822,709
|
)
|
-
|
(32,822,709
|
)
|
||||||||||||||
Research and development expenses
|
(8,469,241
|
)
|
-
|
(8,469,241
|
)
|
(6,362,770
|
)
|
-
|
(6,362,770
|
)
|
||||||||||||||
Provision for doubtful accounts
|
-
|
-
|
-
|
(5,986,308
|
)
|
-
|
(5,986,308
|
)
|
||||||||||||||||
Impairment loss of right-of-use assets
|
-
|
-
|
-
|
(371,695
|
)
|
-
|
(371,695
|
)
|
||||||||||||||||
Impairment loss of intangible assets
|
-
|
-
|
-
|
(2,995,440
|
)
|
-
|
(2,995,440
|
)
|
||||||||||||||||
Impairment of property, plant and equipment
|
(431,319
|
)
|
-
|
(431,319
|
)
|
(550,402
|
)
|
-
|
(550,402
|
)
|
||||||||||||||
Reverse of deferred tax liabilities
|
-
|
-
|
-
|
898,632
|
-
|
898,632
|
||||||||||||||||||
Total operating expenses
|
(52,538,119
|
)
|
-
|
(52,538,119
|
)
|
(54,715,947
|
)
|
-
|
(54,715,947
|
)
|
||||||||||||||
Loss from operations
|
(50,279,859
|
)
|
-
|
(50,279,859
|
)
|
(55,229,917
|
)
|
-
|
(55,229,917
|
)
|
||||||||||||||
OTHER EXPENSE:
|
||||||||||||||||||||||||
Interest income/(expense), net
|
402,414
|
-
|
402,414
|
(844,231
|
)
|
-
|
(844,231
|
)
|
||||||||||||||||
Gain (loss) on redemption of convertible promissory notes
|
12,507
|
-
|
12,507
|
(7,435
|
)
|
-
|
(7,435
|
)
|
||||||||||||||||
(Loss) income from long-term investments
|
(1,377,760
|
)
|
-
|
(1,377,760
|
)
|
(12,651
|
)
|
-
|
(12,651
|
)
|
||||||||||||||
Change in fair value of convertible promissory notes and derivative liability
|
75,341
|
-
|
75,341
|
(37,774,928
|
)
|
-
|
(37,774,928
|
)
|
||||||||||||||||
Change in fair value of equity securities
|
(2,600,721
|
)
|
-
|
(2,600,721
|
)
|
(240,805
|
)
|
-
|
(240,805
|
)
|
||||||||||||||
Convertible bond issuance cost
|
-
|
-
|
(5,589,336
|
)
|
(5,589,336
|
)
|
||||||||||||||||||
Foreign currency exchange loss, net
|
(848,781
|
)
|
-
|
(848,781
|
)
|
(409,207
|
)
|
-
|
(409,207
|
)
|
||||||||||||||
Impairment loss of goodwill
|
-
|
-
|
-
|
(11,111,886
|
)
|
-
|
(11,111,886
|
)
|
||||||||||||||||
Loss from acquisition of Antric
|
(136,302
|
)
|
-
|
(136,302
|
)
|
-
|
-
|
-
|
||||||||||||||||
Loss on exercise of warrants
|
(228,903
|
)
|
(228,903
|
)
|
-
|
-
|
-
|
|||||||||||||||||
Gain from cross-currency swaps
|
8,664
|
8,664
|
-
|
-
|
-
|
|||||||||||||||||||
Other (expense) income, net
|
621,633
|
-
|
621,633
|
(924,867
|
)
|
-
|
(924,867
|
)
|
||||||||||||||||
Loss before income taxes
|
(54,351,767
|
)
|
-
|
(54,351,767
|
)
|
(112,145,263
|
)
|
-
|
(112,145,263
|
)
|
||||||||||||||
Income tax expense
|
(8,988
|
)
|
-
|
(8,988
|
)
|
-
|
-
|
-
|
||||||||||||||||
Net loss
|
(54,360,755
|
)
|
-
|
(54,360,755
|
)
|
(112,145,263
|
)
|
-
|
(112,145,263
|
)
|
||||||||||||||
Less: Net loss attributable to non-controlling interests
|
(161,430
|
)
|
-
|
(161,430
|
)
|
(2,057,022
|
)
|
-
|
(2,057,022
|
)
|
||||||||||||||
Net loss attributable to the Company’s shareholders
|
(54,199,325
|
)
|
-
|
(54,199,325
|
)
|
(110,088,241
|
)
|
-
|
(110,088,241
|
)
|
||||||||||||||
OTHER COMPREHENSIVE LOSS
|
||||||||||||||||||||||||
Foreign currency translation adjustment
|
(1,162,080
|
)
|
-
|
(1,162,080
|
)
|
(3,889,706
|
)
|
-
|
(3,889,706
|
)
|
||||||||||||||
Total comprehensive loss
|
(55,522,835
|
)
|
-
|
(55,522,835
|
)
|
(116,034,969
|
)
|
-
|
(116,034,969
|
)
|
||||||||||||||
Less: total comprehensive loss attributable to non-controlling interests
|
(185,997
|
)
|
-
|
(185,997
|
)
|
(2,032,455
|
)
|
-
|
(2,032,455
|
)
|
||||||||||||||
Total comprehensive loss attributable to the Group’s shareholders
|
(55,336,838
|
)
|
-
|
(55,336,838
|
)
|
(114,002,514
|
)
|
-
|
(114,002,514
|
)
|
a) |
The reclassification of “Accumulated other comprehensive loss” under U.S. GAAP to “Reserves” under IFRS;
|
b) |
The reclassification of amounts of IFRS share-based payments from “Additional paid-in capital” under U.S. GAAP to “Reserves” under
IFRS; and
|
c) |
Additional equity recognized from the difference between the total deemed transaction price and net assets acquired related to the
Combination under IFRS.
|
d) |
In 2021, the Group was deemed to have incurred non-cash listing costs of approximately $209.4 million as a result of the IFRS accounting
treatment of the Combination, as Cenntro was deemed to have received a 67% controlling interest in CEGL (formerly NBG) and the Group was deemed to have incurred listing costs equalling the difference between the total deemed transaction
price and total net assets. Under U.S. GAAP, the Combination is accounted for as a reverse recapitalisation, which is equivalent to the issuance of shares by Cenntro for the net assets of CEGL (formerly NBG), accompanied by a
recapitalisation).
|
• |
The costs of bringing our new facilities into operation;
|
• |
The timing and costs involved in rolling out new ECV models to market;
|
• |
Our ability to manage the costs of manufacturing our ECVs;
|
• |
The costs of maintaining, expanding and protecting our intellectual property portfolio, including potential litigation costs and liabilities;
|
• |
Revenues received from sales of our ECVs;
|
• |
The costs of additional general and administrative personnel, including accounting and finance, legal and human resources, as well as costs related to litigation, investigations, or settlements;
|
• |
Our ability to collect future revenues; and
|
• |
Other risks discussed in the section titled “Risk Factors.”
|
Year Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Net cash used in operating activities
|
$
|
(58,457,164
|
)
|
$
|
(69,401,126
|
)
|
||
Net cash (used in) provided by investing activities
|
(16,388,156
|
)
|
(56,883,397
|
)
|
||||
Net cash provided by financing activities
|
(48,135,595
|
)
|
19,452,636
|
|||||
Effect of exchange rate changes on cash
|
(1,543,989
|
)
|
(736,274
|
)
|
||||
Net (decrease) increase in cash, cash equivalents, and restricted cash
|
(124,524,904
|
)
|
(107,568,161
|
)
|
||||
Cash and cash equivalents, and restricted cash at beginning of the year
|
154,096,801
|
261,664,962
|
||||||
Cash and cash equivalents, and restricted cash at end of the period
|
$
|
29,571,897
|
$
|
154,096, 801
|
Buildings
|
20 years
|
Machinery and equipment
|
5-10 years
|
Office equipment
|
5 years
|
Motor vehicles
|
3-5 years
|
Leasehold improvement
|
3-10 years
|
Others
|
3 years
|
Category
|
Estimated useful life
|
Land use rights
|
45.75-50 years
|
Software
|
3 years
|
Technology
|
5 years
|
Trademark
|
5 years
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Vehicles sales
|
|
$
|
20,344,889
|
|
|
$
|
8,235,053
|
|
Spare-parts sales
|
|
|
1,554,311
|
|
|
|
304,506
|
|
Other service income
|
|
|
180,705
|
|
|
|
402,276
|
|
Net revenues
|
|
$
|
22,079,905
|
|
|
$
|
8,941,835
|
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Primary geographical markets
|
|
|
|
|
||||
Europe
|
$
|
16,218,398
|
$
|
7,052,452
|
||||
Asia
|
4,805,312
|
1,191,931
|
||||||
America
|
|
|
1,056,195
|
|
|
|
697,452
|
|
Total
|
|
$
|
22,079,905
|
|
|
$
|
8,941,835
|
|
December 31,
2023
|
December 31,
2022
|
|||||||
Accounts receivable, net
|
$
|
6,530,801
|
$
|
565,398
|
||||
Contractual liabilities
|
$
|
3,394,044
|
$
|
2,388,480
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Period end USD: RMB exchange rate
|
|
|
7.0999
|
|
|
|
6.8972
|
|
Average USD: RMB exchange rate
|
|
|
7.0809
|
|
|
|
6.7290
|
|
Period end USD: EUR exchange rate
|
1.1062
|
0.9348
|
||||||
Average USD: EUR exchange rate
|
1.0817
|
0.9493
|
December 31,
|
||||||||
2023
|
2022
|
|||||||
PRC
|
$
|
19,900,770
|
$
|
18,018,954
|
||||
US
|
19,730,650
|
9,125,535
|
||||||
Mexico
|
4,238,942
|
|||||||
Dominican
|
808,346
|
469,740
|
||||||
Others
|
2,636,219
|
99,303
|
||||||
Total
|
$
|
47,314,927
|
$
|
27,713,532
|
Item 7A. |
Quantitative and Qualitative Disclosures about Market Risk.
|
Item 8. |
Financial Statements and Supplementary Data
|
PAGE
|
|
F-2 |
|
F-3 |
|
F-4 |
|
F-5 |
|
F-6 |
|
F-7 |
Item 9. |
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
|
Item 9A. |
Controls and Procedures.
|
Item 9B. |
Other Information.
|
Item 10. |
Directors, Executive Officers and Corporate Governance.
|
Name
|
Age
|
Position
|
||
Executive Officers:
|
||||
Peter Z. Wang
|
69
|
Chief Executive Officer, Managing Director and Chairman of the Board
|
||
Edward Ye
|
33
|
Acting Chief Financial Officer
|
||
Wei Zhong
|
46
|
Chief Technology Officer
|
||
Tony W. Tsai
|
51
|
Vice President, Corporate Affairs and Corporate Secretary
|
||
Ming He
|
53
|
Treasurer
|
||
Non-Executive Directors:
|
||||
Yi Zeng
|
68
|
Director
|
||
Stephen Markscheid (1)(2)(3)
|
69
|
Director
|
||
Jiawei “Joe” Tong (1)(2)(3)
|
60
|
Director
|
||
Benjamin B. Ge (1)(2)(3)
|
56
|
Director
|
(1) |
Member of the Audit Committee
|
(2) |
Member of the Compensation Committee
|
(3) |
Member of the Nominating Committee
|
● |
appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors;
|
● |
reviewing with the independent auditors any audit problems or difficulties and management’s response;
|
● |
discussing the annual audited financial statements with management and the independent auditors;
|
● |
reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures;
|
● |
reviewing and approving all proposed related party transactions;
|
● |
meeting separately and periodically with management and the independent auditors; and
|
● |
monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance.
|
● |
reviewing and approving, or recommending to the board for its approval, the compensation for our chief executive officer and other executive officers;
|
● |
reviewing and recommending to the shareholders for determination with respect to the compensation of our directors;
|
● |
reviewing periodically and approving any incentive compensation or equity plans, programs or similar arrangements; and
|
● |
selecting compensation consultant, legal counsel or other adviser only after taking into consideration all factors relevant to that person’s independence from management.
|
● |
selecting and recommending to the board nominees for election by the shareholders or appointment by the board;
|
● |
reviewing annually with the board the current composition of the board with regards to characteristics such as independence, knowledge, skills, experience and diversity;
|
● |
making recommendations on the frequency and structure of board meetings and monitoring the functioning of the committees of the board; and
|
● |
advising the board periodically with regards to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to
the board on all matters of corporate governance and on any remedial action to be taken.
|
Item 11. |
Executive Compensation.
|
• |
Peter Z. Wang, Chief Executive Officer;
|
• |
Edmond Cheng, Former Chief Financial Officer;
|
• |
Ming He, Treasurer; and
|
• |
Tony W. Tsai, Corporate Secretary.
|
Name and Principal Position
|
Fiscal
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)
|
All Other
Compensation
($)
|
Total($)
|
||||||||||||||||
Peter Z. Wang
|
2023
|
350,000
|
1,234,596
|
(1)
|
1,584,596
|
|||||||||||||||||
Chief Executive Officer
|
2022
|
350,000
|
0
|
920,165
|
(1)
|
0
|
1,270,165
|
|||||||||||||||
Edmond Cheng
|
2023(2)
|
300,000
|
464,758
|
(3)
|
464,758
|
|||||||||||||||||
Former Chief Financial Officer
|
2022
|
300,000
|
464,022
|
(3)
|
464,022
|
|||||||||||||||||
Ming He
|
2023
|
250,000
|
53,774
|
(4)
|
303,774
|
|||||||||||||||||
Treasurer
|
2022
|
250,000
|
40,247
|
(4)
|
290,247
|
|||||||||||||||||
Tony W. Tsai
|
2023
|
250,000
|
53,774
|
(5)
|
303,774
|
|||||||||||||||||
Corporate Secretary
|
2022
|
250,000
|
40,247
|
(5)
|
290,247
|
(1) |
On May 3, 2022, Mr. Wang was granted an option to purchase 350,000 shares of common stock of the Company under the former 2022 Stock Incentive Plan (the “2022 Plan”), with an exercise price per share equal to
$1.8480 per share of incentive stock options and $1.6800 per share of non-statutory stock options, which is equal to the price per share of common stock of the Company on the date of grant of the option, out of which 87,500 and 65,625 options
vested during the years ended December 31, 2023, and December 31, 2022, fair value of which is represented here, respectively.
|
(2) |
Mr. Cheng terminated his service as CFO to the Company as of March 1, 2024.
|
(3) |
On December 30, 2021, Mr. Cheng was granted an option to purchase 129,706 shares of common stock under the 2022 Plan, with an exercise price per share equal to $5.74 per share, which is equal to the price per share
of common stock of the Company on the date of grant of the option. The option grant, and adjustment of exercise price to $1.6800 per share, were approved by shareholders at the Annual General Meeting on May 31, 2022, out of which 32,428 and
32,426 options have been vested during the years ended December 31, 2023, and December 31, 2022, fair value of which is represented here, respectively.
|
(4) |
On May 3, 2022, Mr. He was granted an option to purchase 15,000 shares of common stock of the Company under the former 2022 Stock Incentive Plan (the “2022 Plan”), with an exercise price per share equal to $16.800
per share, which is equal to the price per share of common stock of the Company on the date of grant of the option, out of which 3,752 and 2,814 options vested during the years ended December 31, 2023, and December 31, 2022, fair value of
which is represented here, respectively.
|
(5) |
On May 3, 2022, Mr. Tsai was granted an option to purchase 15,000 shares of common stock of the Company under the former 2022 Stock Incentive Plan (the “2022 Plan”), with an exercise price per share equal to $16.800
per share, which is equal to the price per share of common stock of the Company on the date of grant of the option, out of which 3,752 and 2,814 options vested during the years ended December 31, 2023, and December 31, 2022, fair value of
which is represented here, respectively.
|
Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
|
• |
each of our executive officers and directors;
|
• |
all of our current directors and executive officers as a group; and
|
• |
each person or entity, or group of persons or entities, known by us to own beneficially more than 5% of our Common Stock.
|
Name and Address of Beneficial Owner (1)
|
Amount and
Nature of
Beneficial
Ownership
|
Percentage of
Beneficial
Ownership
|
||||||
5% Shareholders:
|
||||||||
China Leader Group Limited (2)
|
1,644,312
|
5.3
|
%
|
|||||
Directors and Executive Officers:
|
||||||||
Peter Z. Wang (3)
|
7,307,560
|
23.7
|
%
|
|||||
Edward Ye (4)
|
30,219
|
*
|
%
|
|||||
Wei Zhong (5)
|
161,017
|
*
|
%
|
|||||
Tony Tsai (6)
|
49,504
|
*
|
%
|
|||||
Jiawei “Joe” Tong (7)
|
6,666
|
*
|
%
|
|||||
Stephen Markscheid
|
-
|
-
|
%
|
|||||
Ming He (8)
|
96,020
|
*
|
%
|
|||||
Yi Zeng
|
-
|
-
|
%
|
|||||
Benjamin B. Ge (9)
|
36,446
|
*
|
%
|
|||||
All current directors and executive officers as a group (eleven persons) (10)
|
7,687,432
|
25
|
%
|
*
|
Represents beneficial ownership of less than 1%.
|
1) |
Unless otherwise indicated, the address for each beneficial owner listed in the table above is c/o Cenntro Inc., 501 Okerson Road, Freehold, New Jersey 07728.
|
2) |
Represents the Acquisition Shares received by China Leader Group Limited (“CLGL”) following the closing of the Combination. CLGL is wholly owned by Yeung Heung Yeung, one of the directors of CAG, the former parent
company of Cenntro. Yeung Heung Yeung has sole voting and dispositive power with respect to the shares of Common Stock held by CLGL. Accordingly, Mr. Yeung may be deemed to beneficially own the 1,644,312 shares of Common Stock directly held
by CLGL. The address of China Leader is Flat B, 29 Floor, Tower 1, Starcrest, 9 Star Street, Wan Chai, Hong Kong.
|
3) |
Consists of (i) 6,539,994 Acquisition Shares held of record by Cenntro Enterprise Limited, (ii) 614,441 Acquisition Shares held of record by Trendway Capital Limited, each of which is wholly owned by Mr. Peter Wang,
and (iii) 153,125 shares of Common Stock that Mr. Wang has the right to acquire from us within 60 days of March 18, 2024, pursuant to the exercise of stock options granted under the 2023 Plan. Mr. Wang has voting and dispositive power over
the securities held by each entity and as a result may be deemed to beneficially own the securities of such entities. Each of Cenntro Enterprise Limited and Trendway Capital Limited received such Acquisition Shares presented above following
the closing of the Combination, pursuant to the Distribution.
|
4) |
Consists of 30,219 shares of Common Stock that Mr. Ye has the right to acquire from us within 60 days of March 18, 2024, pursuant to the exercise of stock options granted under the 2023 Plan.
|
5) |
Consists of 161,017 shares of Common Stock that Mr. Zhong has the right to acquire from us within 60 days of March 18, 2024, pursuant to the exercise of stock options under the 2023 Plan.
|
6) |
Consists of 49,504 shares of Common Stock that Mr. Tsai has the right to acquire from us within 60 days of March 18, 2024, pursuant to the exercise of stock options under the 2023 Plan.
|
7) |
Consists of 6,666 shares of Common Stock that Mr. Tong has the right to acquire from us within 60 days of March 18, 2024, pursuant to the exercise of stock options granted under the 2023 Plan
|
8) |
Consists of 96,020 shares of Common Stock that Mr. He has the right to acquire from us within 60 days of March 18, 2024, pursuant to the exercise of stock options granted under 2023 Plan.
|
9) |
Consists of 29,780 shares of Common Stock beneficially owned by Mr. Ge, and 33,333 shares of Common Stock that Mr. Ge has the right to acquire from us within 60 days of March 18, 2024, pursuant to the exercise of
stock options granted under the 2023 Plan.
|
10) |
Consists of (i) 7,184,215 shares of Common Stock beneficially owned by our directors and executive officers and (ii) 503,217 shares of Common Stock underlying outstanding options, exercisable within 60 days of March
18, 2024.
|
Item 13. |
Certain Relationships and Related Transactions, and Director Independence.
|
Item 14. |
Principal Accounting Fees and Services.
|
SERVICES
|
2023
|
2022
|
||||||
Audit fees
|
$
|
1,012,781
|
$
|
527,307
|
||||
Audit-related fees
|
-
|
51,500
|
||||||
Tax fees
|
-
|
-
|
||||||
All other fees
|
-
|
-
|
||||||
Total fees
|
$
|
1,012,781
|
$
|
578,807
|
Item 15. |
Exhibits and Financial Statement Schedules.
|
(a) |
The following documents are filed as part of this report:
|
(1) |
Financial Statements:
|
(2) |
Financial Schedules:
|
(3) |
Exhibits:
|
(b) |
The following are exhibits to this Report and, if incorporated by reference, we have indicated the document previously filed with the SEC in which the exhibit was included.
|
● |
may have been qualified by disclosures that were made to the other parties in connection with the negotiation of the agreements, which disclosures are not necessarily reflected in the agreements;
|
● |
may apply standards of materiality that differ from those of a reasonable investor; and
|
● |
were made only as of specified dates contained in the agreements and are subject to subsequent developments and changed circumstances.
|
Exhibit Number
|
Description
|
|
Amended and Restated Articles of Incorporation of Cenntro Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K12-b, File No. 001-38544, filed with the SEC on February 27,
2024).
|
||
Scheme Implementation Agreement (dated September 8, 2023 between CEGL and Cenntro Inc.)( incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form
8-K12-b, File No. 001-38544, filed with the SEC on February 27, 2024)
|
||
Cenntro Inc. 2023 Equity Incentive Plan (and Forms of Stock Option Agreement, Cash-Settled Option Agreement, Restricted Stock Agreement and Restricted Stock Unit Agreement (and each agreement’s Notice of
Exercise and Grant Notice, as applicable)) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K12-b, File No. 001-38544, filed with the SEC on February 27, 2024).
|
||
Plant Lease Agreement, dated December 2020, by and between Administrative Commission of Changxing Branch, Huzhou Taihu South Industrial Zone and Cenntro Automotive Group Limited (Hong Kong)
(English Translation) (incorporated by reference to Exhibit 10.8 to the Company’s Report of Foreign Private Issuer on Form 6-K, File No. 001-38544, filed with the SEC on January 5, 2022).
|
||
Employment Agreement, dated August 20, 2017, by and between Mr. Peter Z. Wang and Cenntro Automotive Group Limited (incorporated by reference to Exhibit 10.9 to the Company’s Report of Foreign
Private Issuer on Form 6-K, File No. 001-38544, filed with the SEC on January 5, 2022).
|
Amended and Restated Offer Letter, dated June 28, 2021, by and between Edmond Cheng, Cenntro Automotive Group Limited and, for limited purposes, Cenntro Electric Group, Inc (incorporated by
reference to Exhibit 10.10 to the Company’s Report of Foreign Private Issuer on Form 6-K, File No. 001-38544, filed with the SEC on January 5, 2022).
|
||
Addendum to Amended and Restated Offer Letter, dated October 1, 2021, by and between Mr. Edmond Cheng and Cenntro Automotive Group Limited (incorporated by reference to Exhibit 10.11 to the
Company’s Report of Foreign Private Issuer on Form 6-K, File No. 001-38544, filed with the SEC on January 5, 2022).
|
||
Employment Agreement, dated as of August 20, 2017, by and between Mr. Ming He and Cenntro Automotive Group Limited.
|
||
Employment Agreement, dated as of August 17, 2017, by and between Mr. Tony Tsai and Cenntro Automotive Corporation.
|
||
Entrustment Agreement, dated December 4, 2021, by and between Cenntro Electric Group, Inc. and Cedar Europe GmbH (incorporated by reference to Exhibit 10.21 to the Company’s Report of Foreign
Private Issuer on Form 6-K, File No. 001-38544, filed with the SEC on January 5, 2022).
|
||
Lease Agreement for Commercial Space, dated as of December 26, 2021, by and between Cedar Europe GmbH and Stefan Schoppmann (English Translation) (incorporated by reference to Exhibit 10.22 to
the Company’s Report of Foreign Private Issuer on Form 6-K, File No. 001-38544, filed with the SEC on January 5, 2022).
|
||
Share and Loan Purchase Agreement, dated as of March 5, 2022, by and among Cenntro Electric Group, Inc. and Mosolf SE & Co. KG (incorporated by reference to Exhibit 10.1 to the Report of
Foreign Private Issuer on Form 6-K filed with the SEC on March 9, 2022).
|
||
Lease Agreement, dated January 20, 2022, by and between Jax Industrial One, Ltd., as Landlord, and Cenntro Automotive Corporation, as Tenant, (incorporated by reference to Exhibit 4.26 to the
Annual Report Form 20-F filed by the registrant on April 25, 2022).
|
||
First Lease Amendment, dated as of February 17, 2022, by and among Jax Industrial One, Ltd., as Landlord, Cenntro Automotive Corporation, as Tenant, and Cenntro Electric Group Limited, as
Guarantor, (incorporated by reference to Exhibit 4.27 to the Annual Report Form 20-F filed by the registrant on April 25, 2022).
|
||
Share and Loan Purchase Agreement, dated as of December 13, 2022, by and among Cenntro Electric Group, Inc. and Mosolf SE & Co. KG (incorporated by reference to Exhibit 10.1 to the Report of
Foreign Private Issuer on Form 6-K filed with the SEC on December 16, 2022).
|
||
Placement Agency Agreement, dated as of July 20, 2022 , by and between Cenntro Electric Group Limited and Univest Securities, LLC, as placement agent (incorporated by reference to Exhibit 10.1
to the Report of Foreign Private Issuer on Form 6-K filed with the SEC on July 21, 2022).
|
||
Securities Purchase Agreement, dated as dated as of July 20, 2022 , by and among Cenntro Electric Group Limited and certain accredited investors, (incorporated by reference to Exhibit 10.2 to
the Report of Foreign Private Issuer on Form 6-K filed with the SEC on July 21, 2022).
|
||
Share and Loan Purchase Agreement, dated as of March 5, 2022, by and among Cenntro Electric Group, Inc. and Mosolf SE & Co. KG (incorporated by reference to Exhibit 10.1 to the Report of
Foreign Private Issuer on Form 6-K filed with the SEC on March 9, 2022).
|
||
Cenntro Code of Ethics (incorporated by reference Exhibit 14.1 to the Company’s Current Report on Form 8-K12-b, File No. 001-38544, filed with the SEC on February 27, 2024).
|
||
Cenntro Insider Trading Policy
|
||
List of Subsidiaries.
|
||
Powers of Attorney (the signature page to this registration statement)
|
||
Certification of Principal Executive Officer required by Rule 13a-14(a).
|
||
Certification of Principal Financial Officer required by Rule 13a-14(a).
|
||
Certification required by Section 1350 of Chapter 63 of Title 18 of the United States Code.
|
||
Cenntro Policy Related to Recovery of Erroneously Awarded Compensation
|
||
101. INS
|
Inline XBRL Instance Document.
|
|
101. SCH
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
101. CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
101. DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
101. LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
101. PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
104
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
|
ITEM 16. |
FORM 10-K SUMMARY
|
CENNTRO INC.
|
||
By:
|
/s/ Peter Z. Wang
|
|
Peter Z. Wang
|
||
Chief Executive Officer
|
||
(Principal Executive Officer)
|
By:
|
/s/ Edmond Cheng
|
|
Edmond Cheng
|
||
Chief Financial Officer
|
||
(Principal Accounting Officer)
|
Signature
|
Capacity
|
Date
|
||
/s/ Peter Z. Wang
|
Chairman of the Board and Chief Executive Officer
|
April 1, 2024
|
||
Peter Z. Wang
|
(Principal Executive Officer)
|
|||
/s/ Edward Ye
|
Acting Chief Financial Officer
|
April 1, 2024
|
||
Edward Ye
|
(Principal Accounting Officer)
|
|||
/s/ Benjamin B. Ge
|
Director
|
April 1, 2024
|
||
Benjamin B. Ge
|
||||
/s/ Jiawei “Joe” Tong
|
Director
|
April 1, 2024
|
||
Jiawei “Joe” Tong
|
||||
/s/ Stephen Markscheid
|
Director
|
April 1, 2024
|
||
Stephen Markscheid
|
||||
/s/ Yi Zeng
|
Director
|
April 1, 2024
|
||
Yi Zeng
|
Page
|
|
Consolidated Financial Statements
|
|
F-2 |
|
F-3 | |
F-4 | |
F-5 | |
F-6 | |
F-7 |
Note
|
December 31,
2023
|
December 31,
2022
|
||||||||||
ASSETS
|
||||||||||||
Current assets:
|
||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||||||
Restricted cash
|
|
|
||||||||||
Short-term investment |
4 | |||||||||||
Accounts receivable, net
|
5
|
|
|
|||||||||
Inventories
|
6
|
|
|
|||||||||
Prepayment and other current assets
|
7
|
|
|
|||||||||
|
22
|
|
|
|||||||||
Total current assets
|
|
|
||||||||||
Non-current assets:
|
||||||||||||
Long-term investments
|
8
|
|
|
|||||||||
Investment in equity securities |
9 |
|||||||||||
Property, plant and equipment, net
|
10
|
|
|
|||||||||
Goodwill |
||||||||||||
Intangible assets, net
|
11 |
|
|
|||||||||
Right-of-use assets
|
15
|
|
|
|||||||||
Other non-current assets, net
|
12
|
|
|
|||||||||
Total non-current assets
|
|
|
||||||||||
Total Assets
|
$
|
|
$
|
|
||||||||
LIABILITIES AND EQUITY
|
||||||||||||
LIABILITIES
|
||||||||||||
Current liabilities:
|
||||||||||||
Accounts payable
|
$
|
|
$
|
|
||||||||
Accrued expenses and other current liabilities
|
13
|
|
|
|||||||||
Contractual liabilities
|
2(p)
|
|
|
|
||||||||
Operating lease liabilities, current
|
15
|
|
|
|||||||||
Convertible promissory notes |
16 |
|||||||||||
Contingent liabilities |
||||||||||||
Deferred government grant, current |
||||||||||||
|
22
|
|
|
|||||||||
Total current liabilities
|
|
|
||||||||||
Non-current liabilities: |
||||||||||||
Contingent liabilities non-current |
||||||||||||
Deferred tax liabilities |
||||||||||||
Deferred government grant, non-current |
||||||||||||
Derivative liability - investor warrant |
16 |
|||||||||||
Derivative liability - placement agent warrant |
16 |
|||||||||||
Operating lease liabilities, non-current
|
15
|
|
|
|||||||||
Total non-current liabilities | ||||||||||||
Total Liabilities
|
$
|
|
$
|
|
||||||||
Commitments and contingencies
|
21
|
|||||||||||
EQUITY
|
||||||||||||
Ordinary shares (
|
18 |
|
|
|||||||||
Additional paid in capital
|
|
|
||||||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||||||
Total equity attributable to shareholders
|
|
|
||||||||||
Non-controlling interests
|
(
|
)
|
(
|
)
|
||||||||
Total Equity
|
$
|
|
$
|
|
||||||||
Total Liabilities and Equity
|
$
|
|
$
|
|
For the Years Ended December 31,
|
||||||||||||
Note
|
2023
|
2022
|
||||||||||
Net revenues
|
2(p)
|
|
$
|
|
$
|
|
||||||
Cost of goods sold
|
(
|
)
|
(
|
)
|
||||||||
Gross profit (loss)
|
|
(
|
)
|
|||||||||
|
||||||||||||
OPERATING EXPENSES:
|
||||||||||||
Selling and marketing expenses
|
(
|
)
|
(
|
)
|
||||||||
General and administrative expenses
|
(
|
)
|
(
|
)
|
||||||||
Research and development expenses
|
(
|
)
|
(
|
)
|
||||||||
Provision for doubtful accounts
|
|
(
|
)
|
|||||||||
Impairment loss of right-of-use assets
|
( |
) | ||||||||||
Impairment loss of intangible assets
|
( |
) | ||||||||||
Reverse of deferred tax liabilities
|
||||||||||||
Impairment loss of property, plant and equipment
|
( |
) | ( |
) | ||||||||
Total operating expenses
|
(
|
)
|
(
|
)
|
||||||||
|
||||||||||||
Loss from operations
|
(
|
)
|
(
|
)
|
||||||||
|
||||||||||||
OTHER EXPENSE:
|
||||||||||||
Interest (income)/expense, net
|
|
(
|
)
|
|||||||||
Gain (loss) on redemption of convertible promissory notes
|
( |
) | ||||||||||
(Loss) income from long-term investments
|
8
|
(
|
)
|
(
|
)
|
|||||||
Change in fair value of convertible promissory notes and derivative liability
|
( |
) | ||||||||||
Change in fair value of equity securities
|
( |
) | ( |
) | ||||||||
Convertible bond issuance cost
|
( |
) | ||||||||||
Foreign currency exchange loss, net
|
( |
) | ( |
) | ||||||||
Impairment loss of goodwill
|
( |
) | ||||||||||
Loss from acquisition of Antric
|
( |
) | ||||||||||
Loss on exercise of warrants
|
( |
) | ||||||||||
Gain from cross-currency swaps
|
||||||||||||
Other income/ (expense), net
|
( |
) | ||||||||||
Loss before income taxes
|
(
|
)
|
(
|
)
|
||||||||
Income tax expense
|
14
|
(
|
)
|
|
||||||||
Net loss
|
(
|
)
|
(
|
)
|
||||||||
Less: net loss attributable to non-controlling interests
|
(
|
)
|
(
|
)
|
||||||||
Net loss attributable to the Company’s shareholders
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||
OTHER COMPREHENSIVE LOSS
|
||||||||||||
Foreign currency translation adjustment
|
(
|
)
|
(
|
)
|
||||||||
Total comprehensive loss
|
(
|
)
|
(
|
)
|
||||||||
|
||||||||||||
Less: total comprehensive loss attributable to non-controlling interests
|
(
|
)
|
(
|
)
|
||||||||
Total comprehensive loss to the Company’s shareholders
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||
|
||||||||||||
|
||||||||||||
Weighted average number of shares outstanding, basic and diluted *
|
|
|
||||||||||
|
||||||||||||
Loss per share, basic and diluted
|
19
|
(
|
)
|
(
|
)
|
Ordinary
shares
|
Additional
paid in capital
|
Accumulated
deficit
|
Accumulated
other
comprehensive loss |
Total
shareholders’
equity
|
Non-
controlling interest |
Total equity
|
||||||||||||||||||||||||||
Shares *
|
Amount
|
|||||||||||||||||||||||||||||||
Balance as of January 1, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Exercise of warrants
|
||||||||||||||||||||||||||||||||
Exercise of share-based award
|
||||||||||||||||||||||||||||||||
Net loss
|
-
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
Acquisition of
|
- | |||||||||||||||||||||||||||||||
Foreign currency translation adjustment
|
-
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||||
Balance as of December 31, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||||
Share-based compensation
|
- | |||||||||||||||||||||||||||||||
Net loss
|
- | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
Acquisition of
|
- | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||
Exercise of warrants |
||||||||||||||||||||||||||||||||
Fractional shares issued due to reverse stock split |
||||||||||||||||||||||||||||||||
Foreign currency translation adjustment
|
- | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
Balance as of December 31, 2023
|
( |
) | ( |
) | ( |
) |
For the Year Ended December 31, | ||||||||
2023
|
2022
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Adjustments to reconcile net loss to net cash used in operating activities
|
||||||||
Depreciation and amortization
|
|
|
||||||
Amortization and interest of operating lease right-of-use asset
|
|
|
||||||
Impairment of property, plant and equipment
|
|
|
||||||
Impairment of intangible assets
|
|
|
||||||
Reversal of deferred tax liabilities
|
|
(
|
)
|
|||||
Impairment of right-of-use assets
|
|
|
||||||
Impairment of goodwill
|
|
|
||||||
Written-down of inventories
|
|
|
||||||
Provision for doubtful accounts
|
|
|
||||||
Convertible promissory notes issuance costs
|
|
|
||||||
(Gain) Loss on redemption of convertible promissory notes
|
(
|
)
|
|
|||||
Loss on exercise of warrants
|
||||||||
Changes in fair value of convertible promissory notes and derivative liabilities
|
(
|
)
|
|
|||||
Changes in fair value of equity securities
|
|
|
||||||
Foreign currency exchange loss, net
|
|
|
||||||
Share-based compensation expense
|
|
|
||||||
Loss (Gain) from disposal of plant and equipment
|
|
(
|
)
|
|||||
Loss from long-term investments
|
|
|
||||||
Income from short-term investment
|
( |
) | ||||||
Loss from acquisition of Antric Gmbh
|
||||||||
Deferred income taxes |
( |
) | ||||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable
|
(
|
)
|
|
|||||
Inventories
|
(
|
)
|
(
|
)
|
||||
Prepayment and other assets
|
(
|
)
|
(
|
)
|
||||
Amounts due from/to related parties
|
|
(
|
)
|
|||||
Accounts payable
|
|
(
|
)
|
|||||
Accrued expense and other current liabilities
|
(
|
)
|
|
|||||
Contractual liabilities
|
|
|
||||||
Long-term payable
|
|
(
|
)
|
|||||
Operating lease assets and liabilities
|
(
|
)
|
(
|
)
|
||||
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||
Purchase of equity investment
|
(
|
)
|
(
|
)
|
||||
Purchase of convertible note from Acton
|
(
|
)
|
||||||
Purchase of wealth management products purchased from banks |
( |
) | ||||||
Purchase of land, plant and equipment
|
(
|
)
|
(
|
)
|
||||
Purchase of land use rights and property
|
(
|
)
|
(
|
)
|
||||
Acquisition of CAE’s equity interests
|
(
|
)
|
(
|
)
|
||||
Payment of expense for acquisition of CAE’s equity interests
|
|
(
|
)
|
|||||
Cash acquired from acquisition of CAE
|
|
|
||||||
Acquisition of Antric Gmbh’s equity interests
|
( |
) | ||||||
Cash acquired from acquisition of Antric Gmbh
|
||||||||
Purchase of equity securities
|
|
(
|
)
|
|||||
Proceeds from disposal of property, plant and equipment
|
|
|
||||||
Loans provided to third parties
|
|
(
|
)
|
|||||
Repayment of loans from related parties
|
|
|
||||||
Net cash (used in) provided by investing activities
|
(
|
)
|
(
|
)
|
||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Repayment of loans to related parties
|
|
(
|
)
|
|||||
Repayment of loans to third parties
|
|
(
|
)
|
|||||
Repayments of bank loans
|
(
|
)
|
|
|||||
Purchase of CAE’s loan
|
|
(
|
)
|
|||||
Reduction of capital
|
|
(
|
)
|
|||||
Proceed from issuance of convertible promissory notes
|
|
|
||||||
Redemption of convertible promissory notes
|
(
|
)
|
(
|
)
|
||||
Proceed from exercise of share-based awards
|
|
|
||||||
Payment of expense for the reverse recapitalization
|
|
(
|
)
|
|||||
Net cash provided by financing activities
|
(
|
)
|
|
|||||
Effect of exchange rate changes on cash
|
(
|
)
|
(
|
)
|
||||
Net (decrease)increase in cash, cash equivalents and restricted cash
|
(
|
)
|
(
|
)
|
||||
Cash, cash equivalents and restricted cash at beginning of year
|
|
|
||||||
Cash, cash equivalents and restricted cash at end of year
|
$
|
|
$
|
|
||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||
Interest paid
|
$
|
|
$
|
|
||||
Income tax paid |
$ | $ | ||||||
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
Cashless exercise of warrants
|
$
|
|
$
|
|
||||
Non-cash capital injection to Robostreet by i-Chassis
|
$
|
|
$
|
|
||||
Convention from debt to equity interest of HW Electro Co., Ltd. |
$ | $ | ||||||
Non-cash recognition of new leases |
$ | $ |
Name
|
Date of
Incorporation
|
Place of
Incorporation
|
Percentage of direct or
indirect economic
interest
|
|||
Cenntro Automotive Corporation (“CAC”)
|
|
|
|
|||
Cenntro Electric Group, Inc. (“CEG”)
|
|
|
|
|||
Cennatic Power, Inc. (“Cennatic Power”)
|
|
|
|
|||
Teemak Power Corporation
|
|
|
|
|||
Avantier Motors Corporation
|
|
|
|
|||
Cenntro Electric CICS, SRL
|
|
|
|
|||
Cennatic Energy S. de R.L. de C.V.
|
|
|
|
|||
Cenntro Automotive S.A.S.
|
|
|
|
|||
Cenntro Electric Colombia S.A.S.
|
|
|
|
|||
Cenntro Automotive Group Limited (“CAG HK”)
|
|
|
|
|||
Hangzhou Ronda Tech Co., Limited (“Hangzhou Ronda”)
|
|
|
|
|||
Hangzhou Cenntro Autotech Co., Limited (“Cenntro Hangzhou”)
|
|
|
|
|||
Zhejiang Cenntro Machinery Co., Limited
|
|
|
|
|||
Jiangsu Tooniu Tech Co., Limited
|
|
|
|
|||
Hangzhou Hengzhong Tech Co., Limited
|
|
|
|
|||
Teemak Power (Hong Kong) Limited (HK)
|
|
|
|
|||
Avantier Motors (Hong Kong) Limited
|
|
|
|
|||
Cenntro Automotive Europe GmbH (“CAE”)
|
|
|
|
|||
Cenntro Electric B.V.
|
|
|
|
|||
Cenntro Elektromobilite Araçlar A.Ş
|
|
|
|
|||
Cenntro Elecautomotiv, S.L.
|
|
|
|
|||
Cenntro Electric Group (Europe) GmbH (“CEGE”)
|
|
|
|
|||
Simachinery Equipment Limited (“Simachinery HK”)
|
|
|
|
|||
Zhejiang Sinomachinery Co., Limited (“Sinomachinery Zhejiang”)
|
|
|
|
|||
Shengzhou Cenntro Machinery Co., Limited (“Cenntro Machinery”)
|
|
|
|
|||
Cenntro EV Center Italy S.R.L.
|
|
|
|
|||
Antric Gmbh
|
|
|
|
|||
Pikka Electric Corporation
|
|
|
|
|||
Centro Technology Corporation
|
|
|
|
(a) |
Basis of presentation
|
(b) |
Use of estimates
|
(c) |
Fair value measurement
|
(d)
|
Business combination
|
(e) |
Cash and cash equivalents and restricted cash
|
(f) |
Accounts receivable and provision for doubtful accounts
|
(g) |
Inventories
|
(h)
|
Available-for-sale investments and Debt Security investments
|
(i)
|
Cross-currency
swap
|
(j) |
Investment in equity securities
|
(k) |
Property, plant and equipment, net
|
Buildings
|
|
Machinery and equipment
|
|
Office equipment
|
|
Motor vehicles
|
|
Leasehold improvement
|
|
Others
|
|
(l) |
Intangible assets, net
|
Category
|
Estimated useful life
|
Land use rights
|
|
Software
|
|
Technology |
|
Trademark |
(m) |
Impairment of long-lived assets
|
(n) |
Goodwill
|
(o) |
Long-term investment
|
(p) |
Revenue recognition
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Vehicles sales
|
|
$
|
|
|
|
$
|
|
|
Spare-parts sales
|
|
|
|
|
|
|
|
|
Other service income
|
|
|
|
|
|
|
|
|
Net revenues
|
|
$
|
|
|
|
$
|
|
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Primary geographical markets
|
|
|
|
|
||||
Europe
|
$
|
|
$
|
|
||||
Asia
|
|
|
||||||
America | ||||||||
Total
|
|
$
|
|
|
|
$
|
|
|
December 31,
2023 |
December 31,
2022 |
|||||||
Accounts receivable,
net
|
$
|
|
$
|
|
||||
Contractual liabilities
|
$
|
|
$
|
|
(q) |
Cost of goods sold
|
(r) |
Government grants
|
(s) |
Income taxes
|
(t) |
Foreign currency translation and transaction
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Period end USD: RMB exchange rate
|
|
|
|
|
|
|
|
|
Average USD: RMB exchange rate
|
|
|
|
|
|
|
|
|
Period end USD: EUR exchange rate
|
||||||||
Average USD: EUR exchange rate
|
(u)
|
Comprehensive loss
|
(v) |
Segments
|
December 31,
|
||||||||
2023
|
2022
|
|||||||
PRC
|
$
|
|
$
|
|
||||
US
|
|
|
||||||
Mexico
|
||||||||
Dominican
|
||||||||
Others
|
|
|
||||||
Total
|
$
|
|
$
|
|
(w) |
Share-based compensation expenses
|
(x) |
Convertible promissory notes
|
(y) |
Derivative liability
|
(z) |
Operating lease
|
(aa) |
Non-controlling Interest
|
(ab) |
Recently issued accounting standards pronouncements
|
|
Amount
|
|||
|
||||
Cash and Bank Balance
|
$
|
|
||
Accounts Receivable
|
|
|||
Inventory
|
|
|||
Fixed Assets
|
|
|||
Intangible Assets
|
|
|||
Other assets
|
|
|||
Goodwill
|
|
|||
Short Term Borrowing
|
(
|
)
|
||
Trade and Service Liabilities
|
(
|
)
|
||
Deferred Tax Liabilities
|
(
|
)
|
||
Other Liabilities
|
(
|
)
|
||
Net assets
|
$
|
|
December 31,
2023
|
December 31,
2022
|
|||||||
Available-for-sale investment (1)
|
$
|
|
$
|
|
||||
Cross-currency swap (2)
|
|
|
||||||
Total
|
$ |
|
$ |
|
(1) |
|
(2) |
|
December 31,
2023 |
December 31,
2022 |
|||||||
Accounts receivable
|
$
|
|
$
|
|
||||
Less: provision for doubtful accounts
|
(
|
)
|
(
|
)
|
||||
Accounts receivable, net
|
$
|
|
$
|
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Balance at the beginning of the year
|
$
|
|
$
|
|
||||
Additions
|
|
|
||||||
Write-off
|
(
|
)
|
(
|
)
|
||||
Foreign exchange
|
|
|
||||||
Balance at the end of the year
|
$
|
|
$
|
|
December 31,
2023 |
December 31,
2022 |
|||||||
Raw material
|
$
|
|
$
|
|
||||
Work-in-progress
|
|
|
||||||
Goods in transit
|
||||||||
Finished goods
|
|
|
||||||
Inventories
|
$
|
|
$
|
|
December 31,
2023
|
December 31,
2022
|
|||||||
Advance to suppliers
|
$
|
|
$
|
|
||||
Deductible input value added tax
|
|
|
||||||
Receivable from a third party (1)
|
|
|
||||||
Loans to a third party (2) |
|
|
||||||
Receivable from third parties
|
|
|
||||||
Others
|
|
|
||||||
Prepayment and other current assets
|
$
|
|
$
|
|
(1) |
|
(2) |
|
(a)
|
Equity method investment, net
|
December 31,
2023 |
December 31,
2022 |
|||||||
Antric GmbH (1) | $ | $ | ||||||
Hangzhou Entropy Yu Equity Investment Partnership (Limited Partnership) (“Entropy Yu”) (2) | ||||||||
Hangzhou Hezhe Energy Technology Co., Ltd. (“Hangzhou Hezhe”) (3)
|
|
|
||||||
Able 2rent GmbH (DEU) (4) | ||||||||
Total
|
$
|
|
$
|
|
(1) |
|
(2) |
|
(3) |
|
(4) |
|
(b)
|
Equity investment without readily determinable fair values, net
|
December 31,
2023
|
December 31,
2022
|
|||||||
HW Electro Co., Ltd. (1)
|
$
|
|
$
|
|
||||
Robostreet Inc. (2)
|
|
|
||||||
Total
|
$
|
|
$
|
|
(1)
|
|
(2)
|
|
(c)
|
Debt security investments
|
December 31,
2023
|
December 31,
2022
|
|||||||
MineOne Fix Income Investment I L.P (1)
|
$
|
|
$
|
|
||||
Micro Money Fund SPC (2)
|
|
|
||||||
Total
|
$
|
|
$
|
|
(1)
|
|
(2)
|
|
December 31,
2023 |
December 31,
2022 |
|||||||
At cost:
|
||||||||
Plant and building |
$ | $ | ||||||
Land |
||||||||
Machinery and equipment
|
|
|
||||||
Leasehold improvement
|
|
|
||||||
Office equipment
|
|
|
||||||
Motor vehicles
|
|
|
||||||
Construction in progress
|
||||||||
Total
|
|
|
||||||
Less: accumulated depreciation
|
(
|
)
|
(
|
)
|
||||
Property, plant and equipment, net
|
$
|
|
$
|
|
December 31,
2023
|
December 31,
2022
|
|||||||
At cost:
|
||||||||
Land use right
|
$
|
|
$
|
|
||||
Trademark | ||||||||
Technology | ||||||||
Software
|
|
|
||||||
Total
|
|
|
||||||
Less: accumulated amortization
|
(
|
)
|
(
|
)
|
||||
Intangible assets, net
|
$
|
|
$
|
|
December 31,
2023 |
December 31,
2022 |
|||||||
Loan to the third party (1)
|
$
|
|
$
|
|
||||
Deferred cost (2)
|
|
|
||||||
Deposit (3)
|
|
|
||||||
Long-term prepayment (4)
|
|
|
||||||
Total
|
|
|
||||||
Less: provision for loan to the third party and receivable from a third party
|
|
(
|
)
|
|||||
Other non-current assets, net
|
$
|
|
$
|
|
(1) |
|
(2) |
|
(3) |
|
(4) |
|
December 31,
2023 |
December 31,
2022 |
|||||||
Accrued litigation compensation
|
$
|
|
$
|
|
||||
Accrued expenses | ||||||||
Other taxes payable |
||||||||
Employee payroll and welfare payables
|
|
|
||||||
Accrued professional fees
|
|
|
||||||
Payable for purchasing the factory | ||||||||
Interest expense of convertible loans
|
|
|
||||||
Credit card payable | ||||||||
Others
|
|
|
||||||
Total
|
$
|
|
$
|
|
(1) |
Income taxes
|
|
For the Years Ended December 31,
|
|||||||
|
2023
|
2022
|
||||||
Current
|
$
|
|
$
|
|
||||
Deferred
|
(
|
)
|
|
|||||
Total
|
$
|
|
$
|
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
PRC
|
$
|
(
|
)
|
$
|
(
|
)
|
||
US
|
(
|
)
|
(
|
)
|
||||
Europe
|
(
|
)
|
(
|
)
|
||||
Australia
|
(
|
)
|
(
|
)
|
||||
Others
|
(
|
)
|
|
|||||
Total
|
$
|
(
|
)
|
$
|
(
|
)
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Loss
before provision for income tax
|
$
|
(
|
)
|
$
|
(
|
)
|
||
PRC
statutory income tax rate
|
|
%
|
|
%
|
||||
Income
tax expense at the PRC statutory rate
|
(
|
)
|
(
|
)
|
||||
Effect
of preferential tax rate
|
|
|
||||||
Effect
of international tax rates
|
|
(
|
)
|
|||||
Effect
of non-deductible expenses
|
|
|
||||||
Effect
of research and development deduction
|
(
|
)
|
(
|
)
|
||||
Fair value change of warrant liability | ||||||||
Impairment loss of goodwill | ||||||||
Effect
of valuation allowance
|
|
|
||||||
Total
income tax expense - current
|
|
|
||||||
Effective
income tax rate
|
|
%
|
|
%
|
(2) |
Deferred taxes assets/(liabilities)
|
December 31,
2023
|
December 31,
2022
|
|||||||
Deferred tax assets:
|
||||||||
Impairment loss
|
$
|
|
$ | |||||
Change in fair value of financial instrument
|
(
|
)
|
||||||
Capitalization of research and experimental costs
|
|
|||||||
Net operating loss carry forwards
|
|
|||||||
Total deferred income tax assets
|
|
|||||||
Valuation allowance
|
(
|
)
|
( |
) | ||||
Deferred tax assets, net
|
$
|
|
$ | |||||
Deferred income tax liabilities: | ||||||||
Intangible assets arising from acquisition | ( |
) | ||||||
Total deferred tax liabilities | ( |
) | ||||||
Net deferred tax liabilities | ( |
) |
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Balance at the beginning of the year
|
$
|
|
$
|
|
||||
Additions during the year
|
|
|
||||||
Expire of NOL
|
(
|
)
|
(
|
)
|
||||
Change in tax rate
|
|
(
|
)
|
|||||
Exchange rate effect
|
(
|
)
|
(
|
)
|
||||
Balance at the end of the year
|
$
|
|
$
|
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Operating leases cost excluding short-term rental expense
|
$
|
|
$
|
|
||||
Short-term lease cost
|
|
|
||||||
Total
|
$
|
|
$
|
|
December 31,
2023
|
December 31,
2022
|
|||||||
Cash paid for amounts included in the measurement of lease liabilities
|
$
|
|
$
|
|
||||
Weighted average remaining lease term
|
|
|
||||||
Weighted average discount rate
|
|
%
|
|
%
|
For the year ending December 31,
|
Operating
Leases |
|||
2024
|
$
|
|
||
2025
|
|
|||
2026 |
||||
2027 |
||||
2028 | ||||
2029 and thereafter |
||||
Total lease payments
|
|
|||
Less: imputed interest
|
|
|||
Total
|
$ |
|
||
Less:
|
|
|||
|
|
|
|
Liability component
|
|||
As of December 31, 2022
|
$
|
|
||
Convertible promissory notes issued during the year
|
|
|||
Redemption of convertible promissory notes
|
(
|
)
|
||
Fair value change recognized
|
|
|||
As of December 31, 2023
|
$
|
|
Fair Value Assumptions - Convertible Promissory Note
|
December 31,
2023
|
December 31,
2022
|
||||||
Face value principal payable
|
|
|
||||||
Original conversion price
|
|
|
||||||
Interest Rate
|
|
%
|
|
%
|
||||
Expected term (years)
|
|
|
||||||
Volatility
|
|
%
|
|
%
|
||||
Market yield (range)
|
|
%
|
|
%
|
||||
Risk free rate
|
|
%
|
|
%
|
||||
Issue date
|
|
|
||||||
Maturity date
|
|
|
Investor warrants
component
|
Placement agent
warrants component
|
|||||||
As of December 31, 2022
|
$
|
|
$
|
|
||||
Warrants issued during the year
|
|
|
||||||
Exercise of warrants
|
(
|
)
|
|
|||||
Fair value change recognized
|
(
|
)
|
|
|||||
As of December 31, 2023
|
$ |
|
$ |
|
Fair Value Assumptions – Warrants
|
December 31,
2023
|
December 31,
2022
|
||||||
Expected term (years)
|
|
|
||||||
Volatility
|
|
%
|
|
%
|
||||
Risk free rate
|
|
%
|
|
%
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
General and administrative expenses
|
|
$
|
|
|
|
$
|
|
|
Selling and marketing expenses
|
|
|
||||||
Research and development expenses
|
|
|
|
|
||||
Total
|
|
$
|
|
|
|
$
|
|
|
Number of
Share
Options
|
Weighted
Average
Exercise Price
US$
|
Weighted
Average
Remaining
Contractual
Years
|
Aggregate
Intrinsic
Value
US$
|
|||||||||||||
Outstanding at January 1, 2022
|
|
|
|
|
||||||||||||
Granted
|
|
|
||||||||||||||
Exercised
|
(
|
)
|
|
|||||||||||||
Forfeited
|
(
|
)
|
|
|||||||||||||
Expired
|
(
|
)
|
|
|||||||||||||
Outstanding at December 31, 2022
|
|
|
||||||||||||||
Outstanding at December 31, 2022(After the
“Share Consolidation”)*
|
|
|
|
|
||||||||||||
Granted
|
|
|
||||||||||||||
Exercised
|
|
|
||||||||||||||
Forfeited
|
(
|
)
|
|
|||||||||||||
Expired
|
(
|
)
|
|
|||||||||||||
Outstanding at December 31, 2023
|
|
|
|
|
||||||||||||
Expected to vest at December 31, 2023
|
|
|
|
|
||||||||||||
Exercisable as of December 31, 2023
|
|
|
|
|
For the Years Ended December 31,
|
||||
2023 |
2022
|
|||
Expected volatility
|
|
|
||
Expected dividends yield
|
|
|
||
Risk-free interest rate per annum
|
|
|
||
The fair value of underlying ordinary shares (per share)
|
$ |
$
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
Numerator: | ||||||||
Net loss attributable to the Company’s shareholders
|
(
|
)
|
(
|
)
|
||||
Denominator:
|
||||||||
Weighted average ordinary shares used in computing basic and diluted loss per share *
|
|
|
||||||
Basic and diluted net loss per share
|
(
|
)
|
(
|
)
|
(a)
|
Customers
|
Year ended December 31, 2023 | Year ended December 31, 2022 | |||||||||||||||
Customer
|
Amount
|
% of Total
|
Amount
|
% of Total
|
||||||||||||
A
|
|
|
%
|
|
|
|||||||||||
B |
% | |||||||||||||||
C |
% | |||||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
*
|
|
As of December 31, 2023
|
As of December 31, 2022
|
||||||||||||||||
Customer
|
Amount
|
% of Total
|
Amount
|
% of Total
|
|||||||||||||
A
|
$
|
|
|
%
|
$
|
|
|
|
|||||||||
D |
|
|
|
%
|
|
|
%
|
||||||||||
E |
|
% |
|||||||||||||||
F |
% |
||||||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
(b)
|
Suppliers
|
Year ended December 31, 2023
|
Year ended December 31, 2022
|
|||||||||||||||
Supplier
|
Amount
|
% of Total
|
Amount
|
% of Total
|
||||||||||||
A
|
$
|
|
|
%
|
$
|
|
|
% |
||||||||
B
|
|
|
% |
|
||||||||||||
C | % | |||||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
*
|
Indicates below 10%. |
As of December 31, 2023 | As of December 31, 2022 | |||||||||||||||
Supplier
|
Amount
|
% of Total
|
Amount
|
% of Total
|
||||||||||||
D
|
$
|
|
|
$
|
|
|
% |
|||||||||
C
|
|
|
|
|
% |
|||||||||||
Total
|
$
|
|
|
$
|
|
|
% |
*
|
Indicates below 10%. |
Name of related parties:
|
Relationship with the Company
|
|
Mr. Peter Wang
|
|
|
Mr. Yeung Heung Yeung
|
|
|
Bendon Limited | ||
Zhejiang Zhongchai Machinery Co., Ltd (“Zhejiang Zhongchai”)
|
|
|
Zhejiang RAP
|
|
|
Jiangsu Rongyuan
|
|
|
Hangzhou Hezhe Energy Technology Co., Ltd (“Hangzhou Hezhe”)
|
|
|
Shenzhen Yuanzheng Investment Development Co. Ltd (“Shenzhen Yuanzheng“)
|
|
|
Shanghai Hengyu Enterprise Management Consulting Co., Ltd (“Shanghai Hengyu”)
|
|
|
Antric GmbH | ||
Billy Rafael Romero Del Rosario
|
For the Years Ended December 31,
|
||||||||
2023
|
2022
|
|||||||
|
||||||||
Zhejiang RAP
|
$
|
|
$
|
|
||||
Bendon Limited | ||||||||
Purchase of raw materials from related parties
|
||||||||
Hangzhou Hezhe |
||||||||
Service provided by a related party | ||||||||
Shanghai Hengyu | ||||||||
Zhejiang Zhongchai
|
||||||||
Payment on the purchase of the raw materials |
||||||||
Hangzhou Hezhe | ||||||||
|
||||||||
Prepayment of operating fund to a related party |
||||||||
Billy Rafael Romero Del Rosario |
||||||||
Repayment of the advance operating fund from a related party |
||||||||
Zhejiang Zhongchai |
||||||||
Repayment of interest-bearing Loan from a related party | ||||||||
Shenzhen Yuanzheng | ||||||||
Mr. Yeung Heung Yeung | ||||||||
|
||||||||
Mr. Yeung Heung Yeung
|
|
|
||||||
Others
|
|
|
|
As of December 31,
|
|||||||
|
2023
|
2022
|
||||||
Hangzhou Hezhe (1)
|
$
|
|
$
|
|
||||
Billy Rafael Romero Del Rosario (2)
|
|
|
||||||
Total
|
$
|
|
$
|
|
(1) |
|
(2) |
|
As of December 31,
|
||||||||
2023
|
2022
|
|||||||
Antric GmbH (1) | $ |
$ |
||||||
Zhejiang RAP
|
|
|
||||||
Jiangsu Rongyuan (2)
|
|
|
||||||
Shanghai Hengyu (2)
|
|
|
||||||
Total
|
$
|
|
$
|
|
(1) |
|
(2) |
|
(i)
|
Any material breach by the Company of its obligations under this Agreement which are not cured within ten (10) business days after notice from Executive which sets forth in
reasonable detail the nature of the breach.
|
(ii) |
Any change in Executive’s duties such that Executive is no longer the Company’s Chief Financial Officer, unless such change was made with his consent.
|
(iii) |
Any action on the part of the Company which impairs Executive’s ability to exercise his duties as the Company’s Chief Financial Officer.
|
CENNTRO AUTOMOTIVE GROUP LIMITED
|
By: /s/ Peter Z. Wang |
||
Name: | Peter Z. Wang | |
Title: |
Chairman, and Chief Executive Officer | |
Executive: /s/ Ming He |
CENNTRO AUTOMOTIVE CORPORATION
|
By: /s/ Peter Z. Wang
|
||
Name
|
Peter Z. Wang
|
|
Title:
|
Chairman, and Chief Executive Officer
|
|
Executive: /s/ Tony Wen Tsai
|
(Signature)
|
||
(Please print name)
|
||
Date:
|
Subsidiaries
|
Jurisdiction of Incorporation
|
|
Able2rent GmbH
|
Germany
|
|
Avantier Motors Corporation
|
USA
|
|
Cenntro Automotive Corporation
|
The United States of America
|
|
Cennatic Power, Inc.
|
The United States of America
|
|
Cennatic Energy S. de R.L. de C.V.
|
Mexico
|
|
Cenntro Automotive Europe GmbH
|
Germany
|
|
Cenntro Automotive Group Limited
|
Hong Kong, People’s Republic of China
|
|
Cenntro Automotive S.A.S.
|
Columbia
|
|
Cenntro Electric Group Limited ACN 619 054 938
|
Australia
|
|
Cenntro Elecautomotiv, S.L.
|
Spain
|
|
Cenntro Electric B.V.
|
Netherlands
|
|
Cenntro Electric CICS, SRL
|
Dominican Republic
|
|
Centro Electric Group, Inc.
|
The United States of America
|
|
Cenntro Elektromobilite Araçlar A.Ş
|
Turkey
|
|
Cenntro Electric Group (Europe) GmbH, (f.k.a Blitz F22-1 GmbH)
|
Germany
|
|
Cenntro EV Center Italy S.R.L.
|
Italy
|
|
Cenntro Technology Corporation
|
The United States of America
|
|
Hangzhou Cenntro Autotech Co., Ltd.
|
People’s Republic of China
|
|
Hangzhou Hengzhong Tech Co., Ltd
|
People’s Republic of China
|
|
Hangzhou Ronda Tech Co., Ltd.
|
People’s Republic of China
|
|
Pikka Electric Corporation
|
The United States of America
|
|
Shengzhou Cenntro Machinery Co., Ltd.
|
People’s Republic of China
|
|
Simachinery Equipment Limited
|
Hong Kong, People’s Republic of China
|
|
Teemak Power Corporation
|
USA
|
|
Teemak Power (Hong Kong) Limited
|
Hong Kong, People’s Republic of China
|
|
Zhejiang Cenntro Machinery Co., Ltd.
|
People’s Republic of China
|
|
Zhejiang Sinomachinery Co., Ltd.
|
People’s Republic of China
|
|
Zhejiang Tooniu Tech Co., Ltd.
|
People’s Republic of China
|
|
Zhejiang Xbean Tech Co., Ltd.
|
People’s Republic of China
|
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the company, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c) |
Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and
|
(d) |
Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to
materially affect, the company’s internal control over financial reporting; and
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record,
process, summarize and report financial information; and
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
|
Dated: April 1, 2024
|
||
By:
|
/s/ Peter Z. Wang
|
|
Peter Z. Wang
|
||
Chairman and Chief Executive Officer
|
||
(Principal Executive Officer)
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the company, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c) |
Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and
|
(d) |
Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to
materially affect, the company’s internal control over financial reporting; and
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record,
process, summarize and report financial information; and
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
|
Dated: April 1, 2024
|
|
|
|
By:
|
/s/ Edward Ye
|
|
|
Edward Ye
|
|
|
Acting Chief Financial Officer
|
|
|
(Principal Accounting Officer and Principal Financial Officer)
|
Dated: April 1, 2024
|
||
By:
|
/s/ Peter Z. Wang
|
|
Peter Z. Wang
|
||
Chairman and Chief Executive Officer
|
||
By:
|
/s/ Edward Ye
|
|
Edward Ye
|
||
Acting Chief Financial Officer
|
1.
|
Miscalculation of Financial Performance Measure Results. In the event of a Restatement, the Company will seek to recover,
reasonably promptly, all Recoverable Incentive Compensation from a Covered Officer during the Applicable Period. Such recovery, in the case of a Restatement, will be made without regard to any individual knowledge or responsibility
related to the Restatement or the Recoverable Incentive Compensation. Notwithstanding the foregoing, if the Company is required to undertake a Restatement, the Company will not be required to recover the Recoverable Incentive Compensation
if the Compensation Committee determines it Impracticable to do so, after exercising a normal due process review of all the relevant facts and circumstances. he Company will seek to recover all Recoverable Incentive Compensation that was
awarded or paid in accordance with the definition of “Recoverable Incentive Compensation” set forth on the Definitions Exhibit. If such Recoverable Incentive Compensation was not awarded or paid on a formulaic basis, the Company will seek
to recover the amount that the Compensation Committee determines in good faith should be recouped.
|
2. |
Legal and Compliance Violations. Compliance with the law and the Company’s Standards of Business Conduct and other corporate policies is a pre-condition to earning Incentive Compensation. If the
Company in its sole discretion concludes that a Covered Officer (1) committed a significant legal or compliance violation in connection with the Covered Officer’s employment, including a violation of the Company’s corporate policies or the
Company’s Standards of Business Conduct (each, “Misconduct”), or (2) was aware of or willfully blind to Misconduct that occurred in an area over which the Covered Officer had supervisory authority, the Company may, at the direction
of the Compensation Committee, seek recovery of all or a portion of the Recoverable Incentive Compensation awarded or paid to the Covered Officer for the Applicable Period in which the violation occurred. In addition, the Company may, at
the direction of the Compensation Committee, conclude that any unpaid or unvested Incentive Compensation has not been earned and must be forfeited.
|
3. |
Other Actions. The Compensation Committee may, subject to applicable law, seek recovery in the manner it chooses, including by seeking reimbursement from the Covered Officer of all or part of the
compensation awarded or paid, by electing to withhold unpaid compensation, by set-off, or by rescinding or canceling unvested stock.
|
4. |
No Indemnification or Reimbursement. Notwithstanding the terms of any other policy, program, agreement or arrangement, in no event will the Company or any of its affiliates indemnify or reimburse
a Covered Officer for any loss under this Policy and in no event will the Company or any of its affiliates pay premiums on any insurance policy that would cover a Covered Officer’s potential obligations with respect to Recoverable Incentive
Compensation under this Policy.
|
5. |
Administration of Policy. The Compensation Committee will have full authority to administer this Policy. Actions of the Compensation Committee pursuant to this Policy will be taken by the vote of
a majority of its members. The Compensation Committee will, subject to the provisions of this Policy and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Company’s applicable exchange
listing standards, make such determinations and interpretations and take such actions in connection with this Policy as it deems necessary, appropriate or advisable. All determinations and interpretations made by the Compensation Committee
will be final, binding and conclusive.
|
6. |
Other Claims and Rights. The remedies under this Policy are in addition to, and not in lieu of, any legal and equitable claims the Company or any of its affiliates may have or any actions that may
be imposed by law enforcement agencies, regulators, administrative bodies, or other authorities. Further, the exercise by the Compensation Committee of any rights pursuant to this Policy will not impact any other rights that the Company or
any of its affiliates may have with respect to any Covered Officer subject to this Policy.
|
7. |
Condition to Eligibility for Incentive Compensation. All Incentive Compensation subject to this Policy will not be earned, even if already paid, until the Policy ceases to apply to such Incentive
Compensation and any other vesting conditions applicable to such Incentive Compensation are satisfied.
|
8. |
Amendment; Termination. The Board or the Compensation Committee may amend or terminate this Policy at any time.
|
9. |
Effectiveness. Except as otherwise determined in writing by the Compensation Committee, this Policy will apply to any Incentive Compensation that (a) in the case of any Restatement, is Received by
Covered Officers prior to, on or following the Effective Date, and (b) in the case of Misconduct, is awarded or paid to a Covered Officer on or after the Effective Date. This Policy will survive and continue notwithstanding any termination
of a Covered Officer’s employment with the Company and its affiliates.
|
10. |
Successors. This Policy shall be binding and enforceable against all Covered Officers and their successors, beneficiaries, heirs, executors, administrators, or other legal representatives.
|
11. |
Governing Law. To the extent not preempted by U.S. federal law, this Policy will be governed by and construed in accordance with the laws of the State of New York, without reference to principles
of conflict of laws.
|